Anna Kutschenko

640 total citations
20 papers, 273 citations indexed

About

Anna Kutschenko is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Anna Kutschenko has authored 20 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Anna Kutschenko's work include Botulinum Toxin and Related Neurological Disorders (10 papers), Neurological disorders and treatments (8 papers) and Hereditary Neurological Disorders (3 papers). Anna Kutschenko is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (10 papers), Neurological disorders and treatments (8 papers) and Hereditary Neurological Disorders (3 papers). Anna Kutschenko collaborates with scholars based in Germany, United States and Switzerland. Anna Kutschenko's co-authors include David Liebetanz, Arne Wrede, Dorothee Wachter, Veit Rohde, Michael A. Nitsche, Walter Schulz‐Schaeffer, Florian Wegner, Martin Klietz, Stefan Hesse and Andreas Rummel and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Diabetologia.

In The Last Decade

Anna Kutschenko

20 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kutschenko Germany 9 133 95 88 35 34 20 273
Caio M. Matias United States 12 192 1.4× 58 0.6× 126 1.4× 24 0.7× 21 0.6× 48 392
R. Vanninen Finland 10 173 1.3× 96 1.0× 49 0.6× 29 0.8× 27 0.8× 11 378
Anna Zicca Italy 5 74 0.6× 149 1.6× 36 0.4× 30 0.9× 34 1.0× 8 293
Christos Moschovos Greece 10 107 0.8× 31 0.3× 85 1.0× 51 1.5× 47 1.4× 29 316
Xinguang Yu China 12 206 1.5× 103 1.1× 62 0.7× 13 0.4× 56 1.6× 29 413
Namiko Nishida Japan 12 188 1.4× 42 0.4× 78 0.9× 18 0.5× 51 1.5× 38 465
Shaun Rodgers United States 9 144 1.1× 114 1.2× 64 0.7× 51 1.5× 58 1.7× 27 314
Tommy Bosman Belgium 8 163 1.2× 102 1.1× 88 1.0× 32 0.9× 17 0.5× 11 351
T Nakamuro Japan 8 121 0.9× 109 1.1× 64 0.7× 21 0.6× 47 1.4× 18 269
Louise Trevillion Australia 8 215 1.6× 150 1.6× 188 2.1× 92 2.6× 19 0.6× 13 490

Countries citing papers authored by Anna Kutschenko

Since Specialization
Citations

This map shows the geographic impact of Anna Kutschenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kutschenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kutschenko more than expected).

Fields of papers citing papers by Anna Kutschenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kutschenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kutschenko. The network helps show where Anna Kutschenko may publish in the future.

Co-authorship network of co-authors of Anna Kutschenko

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kutschenko. A scholar is included among the top collaborators of Anna Kutschenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kutschenko. Anna Kutschenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schunk, Mirjam, John Ervin, Christoph Schindler, et al.. (2024). A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity. Human Vaccines & Immunotherapeutics. 20(1). 2410574–2410574. 3 indexed citations
2.
Kutschenko, Anna, et al.. (2021). Intramuscular tetanus neurotoxin reverses muscle atrophy: a randomized controlled trial in dogs with spinal cord injury. Journal of Cachexia Sarcopenia and Muscle. 13(1). 443–453. 3 indexed citations
3.
Kutschenko, Anna, Sabine Schröder, Roland Blume, et al.. (2021). Regulation of dual leucine zipper kinase activity through its interaction with calcineurin. Cellular Signalling. 82. 109953–109953. 2 indexed citations
4.
Kutschenko, Anna, H. Baumann, Hannes Glaß, et al.. (2021). Reduced Expression of GABAA Receptor Alpha2 Subunit Is Associated With Disinhibition of DYT-THAP1 Dystonia Patient-Derived Striatal Medium Spiny Neurons. Frontiers in Cell and Developmental Biology. 9. 650586–650586. 8 indexed citations
5.
Kutschenko, Anna, Karen Grütz, Hannes Glaß, et al.. (2021). Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons. International Journal of Molecular Sciences. 22(7). 3565–3565. 8 indexed citations
6.
Klietz, Martin, et al.. (2021). Validation of the Parkinson’s Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy. Parkinson s Disease. 2021. 1–7. 3 indexed citations
7.
Kutschenko, Anna, Martin Klietz, Lejla Paracka, et al.. (2020). Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study. Journal of Neural Transmission. 127(8). 1161–1165. 11 indexed citations
8.
Hesse, Stefan, et al.. (2020). Therapeutic effects of Tetanus neurotoxin in spinal cord injury: a case series on four dogs. Spinal Cord Series and Cases. 6(1). 9–9. 4 indexed citations
9.
Klietz, Martin, Katja Kollewe, Lejla Paracka, et al.. (2019). Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study. Journal of Neural Transmission. 127(1). 61–70. 15 indexed citations
10.
Kutschenko, Anna, Hans Bigalke, Florian Wegner, & Kai Wohlfarth. (2019). The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products. Toxicon. 168. 158–163. 12 indexed citations
11.
Kutschenko, Anna, Jasmin Weisemann, Katja Kollewe, et al.. (2019). Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients. Clinical Neurophysiology. 130(6). 1066–1073. 9 indexed citations
12.
Bremer, Sebastian, Kristian Hellenkamp, Nico Hartmann, et al.. (2016). Enhanced cardiac TBC1D10C expression lowers heart rate and enhances exercise capacity and survival. Scientific Reports. 6(1). 33853–33853. 4 indexed citations
13.
Kutschenko, Anna, et al.. (2016). In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA. Neuroscience Letters. 627. 216–221. 30 indexed citations
14.
Kutschenko, Anna, et al.. (2016). BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild-type in murine running wheel assay. NeuroToxicology. 59. 1–8. 12 indexed citations
15.
Kutschenko, Anna, et al.. (2011). Botulinum toxin‐induced focal paresis in mice is unaffected by muscle activity. Muscle & Nerve. 44(6). 930–936. 7 indexed citations
16.
Kutschenko, Anna, et al.. (2011). Accurate quantification of tetanus neurotoxin-induced focal spasticity in mice using complex running wheels. Journal of Neuroscience Methods. 205(1). 45–48. 8 indexed citations
17.
Kutschenko, Anna, et al.. (2010). Anfallszunahme durch Valproat bei primär generalisierter Epilepsie. Der Nervenarzt. 82(2). 226–230. 1 indexed citations
18.
Kutschenko, Anna & David Liebetanz. (2010). Meningioma causing gabapentin-responsive secondary SUNCT syndrome. The Journal of Headache and Pain. 11(4). 359–361. 12 indexed citations
19.
Wachter, Dorothee, Arne Wrede, Walter Schulz‐Schaeffer, et al.. (2010). Transcranial direct current stimulation induces polarity-specific changes of cortical blood perfusion in the rat. Experimental Neurology. 227(2). 322–327. 96 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caio M. Matias Breakdown of academic impact, for papers by R. Vanninen Breakdown of academic impact, for papers by Anna Zicca Breakdown of academic impact, for papers by Christos Moschovos Breakdown of academic impact, for papers by Xinguang Yu Breakdown of academic impact, for papers by Namiko Nishida Breakdown of academic impact, for papers by Shaun Rodgers Breakdown of academic impact, for papers by Tommy Bosman Breakdown of academic impact, for papers by T Nakamuro Breakdown of academic impact, for papers by Louise Trevillion
Rankless by CCL
2026